CR Bard

C. R. Bard, Inc. was a significant American medical technology company founded in 1907 by Charles Russell Bard. Initially focused on a European urinary treatment, the company grew to develop, manufacture, and market a wide range of healthcare products, particularly in urology, vascular medicine, oncology, and surgery. Bard was known for its innovation in catheter technology and expanded into various medical specialties throughout its history. The company produced over 800 medical products, including the Foley catheter, angioplasty catheters, arterial prostheses, and devices for cancer treatment. Bard served healthcare providers such as hospitals, clinics, and extended care facilities, catering to specialists in urology, cardiology, radiology, anesthesiology, and surgery. Bard was publicly traded and became one of the largest medical technology companies globally before its acquisition by Becton Dickinson in 2017.

• Employees 2300
• Founded 1907